Associated Papers
A mutation in CCDC91, Homo sapiens coiled-coil domain containing 91 protein, cause autosomal-dominant acrokeratoelastoidosis.
Zhu Y et al.
European Journal of Human Genetics : Ejhg, 2024
Case report: Two unique nonsense mutations in HTRA1-related cerebral small vessel disease in a Chinese population and literature review.
Chen W et al.
Frontiers in Neurology, 2022
Pharmacogenetics of drug dependence: Polymorphisms of genes involved in glutamate neurotransmission.
Nudmamud-Thanoi S et al.
Neuroscience Letters, 2020
GRIN2B Gene Polymorphism in Chronic Ketamine Users.
Fan N et al.
The American Journal on Addictions, 2020
On the path towards personalized medicine: Implications of pharmacogenetic studies of alcohol use disorder medications.
Nieto SJ et al.
Expert Review of Precision Medicine and Drug Development, 2020
Implication of Genes for the N-Methyl-D-Aspartate (NMDA) Receptor in Substance Addictions.
Chen J et al.
Molecular Neurobiology, 2018
Association between N-methyl-D-aspartate Receptor Subunit 2B Gene Polymorphisms and Personality Traits in a Young Japanese Population.
Narita S et al.
East Asian Archives of Psychiatry : Official Journal of the Hong Kong College of Psychiatrists = Dong Ya Jing Shen Ke Xue Zhi : Xianggang Jing Shen Ke Yi Xue Yuan Qi Kan, 2018
Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson's disease patients.
Krishnamoorthy S et al.
Parkinsonism & Related Disorders, 2016
Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine.
Taylor DL et al.
Human Psychopharmacology, 2016
Pharmacogenetics of clozapine response and induced weight gain: A comprehensive review and meta-analysis.
Gressier F et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology, 2016
DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson's disease patients.
Zainal Abidin S et al.
Bmc Neurology, 2015
The pharmacogenetics of alcohol use disorder.
Jones JD et al.
Alcoholism, Clinical and Experimental Research, 2015
Association of genetic variants of GRIN2B with autism.
Pan Y et al.
Scientific Reports, 2015
Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer's disease.
Andreoli V et al.
Journal of Neural Transmission (vienna, Austria : 1996), 2014
Genetic susceptibility of impulse control and related behavior in Parkinson's disease.
Kim YE et al.
Journal of Parkinson's Disease, 2014
Polymorphisms in microRNA target sites influence susceptibility to schizophrenia by altering the binding of miRNAs to their targets.
Gong Y et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology, 2013
Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population.
Almoguera B et al.
The Pharmacogenomics Journal, 2013
Pharmacogenetically driven treatments for alcoholism: are we there yet?
Arias AJ et al.
Cns Drugs, 2012
An association study of the genetic polymorphisms in 13 neural plasticity-related genes with semantic and episodic memories.
Gong P et al.
Journal of Molecular Neuroscience : Mn, 2012
NMDA receptor gene variations as modifiers in Huntington disease: a replication study.
Saft C et al.
Plos Currents, 2011
Pharmacogenetics of new analgesics.
Lötsch J et al.
British Journal of Pharmacology, 2011
Differential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson's disease.
Lee JY et al.
Movement Disorders : Official Journal of the Movement Disorder Society, 2011
The influence of genetic and environmental factors among MDMA users in cognitive performance.
Cuyàs E et al.
Plos One, 2011
Association between NMDA receptor subunit 2b gene polymorphism and Alzheimer's disease in Chinese Han population in Shanghai.
Chen C et al.
Neuroscience Bulletin, 2010
Dissociable influences of NR2B-receptor related neural transmission on functions of distinct associative basal ganglia circuits.
Beste C et al.
Neuroimage, 2010
Association analysis of GRIN1 and GRIN2B polymorphisms and Parkinson's disease in a hospital-based case-control study.
Wu SL et al.
Neuroscience Letters, 2010
Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance.
Cherlyn SY et al.
Neuroscience and Biobehavioral Reviews, 2010
Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease.
Lee JY et al.
Movement Disorders : Official Journal of the Movement Disorder Society, 2009
Lack of association of three GRIN2B polymorphisms with bipolar disorder.
Szczepankiewicz A et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry, 2009
Ancillary risk information and pharmacogenetic tests: social and policy implications.
Henrikson NB et al.
The Pharmacogenomics Journal, 2008
ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease.
Arning L et al.
Journal of Molecular Medicine (berlin, Germany), 2008
Association analysis of polymorphisms in the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GRIN2B) gene and tardive dyskinesia in schizophrenia.
Liou YJ et al.
Psychiatry Research, 2007
NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner.
Arning L et al.
Human Genetics, 2007
Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a HuGE review and meta-analysis.
Li D et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2007
An association study of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray.
Qin S et al.
European Journal of Human Genetics : Ejhg, 2005
NR2A and NR2B receptor gene variations modify age at onset in Huntington disease.
Arning L et al.
Neurogenetics, 2005
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.
Kirchheiner J et al.
Molecular Psychiatry, 2004
Polymorphisms in the N-methyl-D-aspartate receptor 1 and 2B subunits are associated with alcoholism-related traits.
Wernicke C et al.
Biological Psychiatry, 2003
Association analysis of the genetic variants of the N-methyl D-aspartate receptor subunit 2b (NR2b) and treatment-refractory schizophrenia in the Chinese.
Chiu HJ et al.
Neuropsychobiology, 2003
Association analysis for genetic variants of the NMDA receptor 2b subunit (GRIN2B) and Parkinson's disease.
Tsai SJ et al.
Journal of Neural Transmission (vienna, Austria : 1996), 2002
Dopamine D2 receptor and N-methyl-D-aspartate receptor 2B subunit genetic variants and intelligence.
Tsai SJ et al.
Neuropsychobiology, 2002
Identification of a novel variant of the human NR2B gene promoter region and its possible association with schizophrenia.
Miyatake R et al.
Molecular Psychiatry, 2002
Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia.
Ohtsuki T et al.
Molecular Psychiatry, 2001
Novel polymorphism in the gene region encoding the carboxyl-terminal intracellular domain of the NMDA receptor 2B subunit: analysis of association with schizophrenia.
Nishiguchi N et al.
The American Journal of Psychiatry, 2000
Association of N-Methyl-D-Aspartate receptor 2B Subunit (GRIN2B) polymorphism with earlier age at onset of withdrawal symptoms in Indian alcohol dependent subjects.
Paul P et al.
Journal of Addictive Diseases, 0